Product Details for ANDA 083266
AMNESTROGEN (ESTROGENS, ESTERIFIED)
0.3MG
Marketing Status: Discontinued
0.625MG
Marketing Status: Discontinued
1.25MG
Marketing Status: Discontinued
2.5MG
Marketing Status: Discontinued
0.3MG
Marketing Status: Discontinued
Active Ingredient: ESTROGENS, ESTERIFIED
Proprietary Name: AMNESTROGEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.3MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083266
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
AMNESTROGEN (ESTROGENS, ESTERIFIED)
Proprietary Name: AMNESTROGEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.3MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083266
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
0.625MG
Marketing Status: Discontinued
Active Ingredient: ESTROGENS, ESTERIFIED
Proprietary Name: AMNESTROGEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.625MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083266
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
AMNESTROGEN (ESTROGENS, ESTERIFIED)
Proprietary Name: AMNESTROGEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.625MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083266
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
1.25MG
Marketing Status: Discontinued
Active Ingredient: ESTROGENS, ESTERIFIED
Proprietary Name: AMNESTROGEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083266
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
AMNESTROGEN (ESTROGENS, ESTERIFIED)
Proprietary Name: AMNESTROGEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083266
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
2.5MG
Marketing Status: Discontinued
Active Ingredient: ESTROGENS, ESTERIFIED
Proprietary Name: AMNESTROGEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083266
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: AMNESTROGEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083266
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information